Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Acrivon Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20
Revenues23.913.71.9
            Revenue growth74.6%621.2% 
Cost of goods sold32.716.23.2
Gross profit-8.7-2.5-1.3
            Gross margin-36.4%-18.0%-66.6%
General and administrative8.72.51.3
EBIT-32.7-16.2-3.2
            EBIT margin-136.4%-118.0%-166.6%
Pre-tax income-31.2-16.20.0
Income taxes0.00.00.0
            Tax rate0.0%0.0% 
Net income-31.2-16.20.0
            Net margin-130.1%-118.4%0.0%
 
Diluted EPS($7.56)($9.32)$0.00
Shares outstanding (diluted)4.11.71,432.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy